Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
stapuldencel
- Development stage
- Phase 3
- Lead developer
- SOTIO Biotech AG
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies
- Administration
- Subcutaneous
01
Overview
Stapuldencel (also known as stapuldencel-T or DCVAC/PCa) is an autologous dendritic cell-based active cellular immunotherapy developed by Sotio Biotech. The therapy is produced by collecting a patient's own dendritic cells and pulsing them ex vivo with a prostate tumor cell lysate that contains a broad spectrum of tumor-associated antigens (TAAs). This process is designed to activate the dendritic cells, which, upon re-administration to the patient, stimulate a T-cell mediated immune response against prostate cancer cells. Stapuldencel has been evaluated in several clinical settings, most notably in the Phase III VIABLE trial for metastatic castration-resistant prostate cancer (mCRPC), as well as in Phase II trials for localized and metastatic prostate cancer.
- Other names
- stapuldencel-TDCVAC
Beyond the preview
Go deeper on stapuldencel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on stapuldencel.